Related Experiment Video
Updated: Aug 3, 2026

10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.2K
Hyalocytes in proliferative vitreo-retinal diseases
Charlotte H Jones1, Wei Gui2, Ricarda G Schumann3
1Cornell University, Ithaca, New York, USA.
Expert Review of Ophthalmology
|December 5, 2022
Summary
Hyalocytes, macrophages in the eye, contribute to vision-impairing diseases. Early intervention targeting these cells may prevent severe conditions like proliferative vitreo-retinopathy.
Area of Science:
- Ophthalmology
- Retinal Biology
- Cellular Biology
Background:
- Hyalocytes are specialized macrophages located in the posterior vitreous cortex.
- They are situated anterior to the retinal inner limiting membrane (ILM).
- Anomalous posterior vitreous detachment (PVD) and vitreoschisis involve hyalocytes in retinal diseases.
Purpose of the Study:
- To investigate the role of hyalocytes in the pathophysiology of various retinal diseases.
- To explore the potential of targeting hyalocytes for therapeutic intervention.
- To understand how hyalocytes contribute to both paucicellular and hypercellular vitreoretinal conditions.
Main Methods:
- Studies utilized human tissues.
- Employing dark-field, phase, and electron microscopy.
- Immunohistochemistry and in vivo imaging of human hyalocytes were performed.
Main Results:
- Hyalocytes are implicated in the early stages of disease pathophysiology.
- They stimulate cell migration, proliferation, membrane contraction, and vitreo-retinal traction.
- Hyalocyte involvement ranges from paucicellular diseases (e.g., macular holes) to hypercellular diseases (e.g., proliferative diabetic vitreo-retinopathy).
Conclusions:
- Early targeting of hyalocytes may mitigate the progression of advanced retinal diseases.
- Eliminating the role of vitreous and hyalocytes could potentially prevent proliferative vitreo-retinal diseases.
- Understanding hyalocyte function is crucial for developing novel therapeutic strategies.

